First Patent Application For Dual Gene Therapy Targeting The Aging Process

17 June 2016

BioViva USA Inc. files for patent for dual gene therapy to restore telomere attrition and muscle degradation caused by aging

In 2015 the CEO of BioViva USA Inc. received her company’s first restorative, dual gene therapy for aging. Following promising results, BioViva seeks to patent the effective new technology.

Leave a Reply

Your email address will not be published. Required fields are marked *